LetsGetChecked’s Post

As a result of an increase in adolescent inpatient visits with a sexually transmitted infection (#STI) diagnosis in 2020, further work is needed to improve #STIcare, particularly for this demographic. https://lnkd.in/eFJKVqqU #Pharmacy #PatientCare #STILearning #STIeducation Drug Topics

In late 2022, a study between the School of Public Health, School of Nursing, and Public Health - Seattle & King County, explored attitudes toward leave-behind naloxone, buprenorphine, and HIV/HCV testing among first responders and people who use drugs. The findings led to the implementation of several recommendations, including making naloxone more accessible in public high schools, and a pilot program with Seattle’s Fire Department to administer buprenorphine after overdoses. A new five-year study will continue to examine how the policies have impacted people of color who use drugs in King County. https://lnkd.in/gwpTdkZH #PublicHealth #PublicHealthResearch

#ESMOBreast24: Breast cancer survivors often face sexual health challenges, including genitourinary syndrome of menopause (GSM) and negative body image. Two studies address these challenges discussing the benefits and risks of the use of topical hormonal treatments for GSM, and the positive impact of physical exercise on reducing fatigue, thus improving sexual desire and quality of life. 👇In this #ESMODailyReporter article Don S. Dizon highlights how the medical community needs to embrace the concept that sexual health is frequently impacted after cancer and, as such, it should be part of the general health review for all our patients. https://ow.ly/AAQ750RJrje

Shedding light on Female Genital Mutilation (FGM) Female Genital Mutilation, or FGM includes procedures involving the partial or total removal of external female genitalia, driven by cultural or non-medical motives. The World Health Organization (WHO) categorizes FGM into four types: Type I (Clitoridectomy): Partial or total removal of the clitoral glans and/or prepuce. Type II (Excision): Partial or total removal of the clitoral glans, labia minora, with or without excision of labia majora. Type III (Infibulation): Narrowing the vaginal orifice with a covering seal. Type IV: All other harmful procedures for non-medical purposes, such as pricking, piercing, incising, scraping, or cauterization. FGM poses immediate and long-term risks to psychological, obstetric, genitourinary, sexual, and reproductive health. Importantly, there is no health benefit from FGM. Rather, it has short term and long-term consequences such as hemorrhage, shock, severe pain and bleeding, complications during childbirth, anaemia, cyst and abscess formation, keloid scar formation, urethral damage leading to urinary incontinence, dyspareunia (painful sexual intercourse), sexual dysfunction, hypersensitivity of the genital area, potential HIV transmission risk, and psychological effects. The world has evolved over the practice of FGM. Lend your voice and knowledge to the end of FGM. Let it end with you and I. Let's unite in protecting current and future generations of girls from the perils of this practice. Together, we can make a difference! #EndFGM #ProtectOurGirls #unfpa #worldhealthorganization #HealthForAll #WomenEmpowerment@ #genderbasedviolence #genderequality

1 in 3 Women Have Lasting Health Problems After Giving Birth: Study More than 1 in 3 women worldwide (at least 40 million women) annually experience lasting health problems in the months or years following childbirth, according to a new study published in The Lancet Global Health. Those problems include pain during sexual intercourse (35%), low back pain (32%), urinary incontinence (8% to 31%), anxiety (9% to 24%), anal incontinence (19%), depression (11% to 17%), fear of childbirth (6% to 15%), perineal pain (11%), and secondary infertility (11%). Other problems included pelvic organ prolapse, posttraumatic stress disorder, thyroid dysfunction, mastitis, HIV seroconversion (when the body begins to produce detectable levels of HIV antibodies), nerve injury, and psychosis. The study says most women see a doctor 6 to 12 weeks after birth and then rarely talk to doctors about these nagging health problems. Many of the problems don't show up until 6 or more weeks after birth. https://lnkd.in/ganHGH6h

Depression is common among people living with HIV (PLWH) and negatively impacts adherence to the care cascade and clinical outcomes. In low-resource settings that lack mental health professionals to identify and diagnose depression, structured screening instruments are often used by non-specialists to generate ratings of patient symptoms. Among the screening instruments, the nine-item Patient Health Questionnaire (PHQ-9) is widely used. Although the PHQ-9 has been shown to have high sensitivity and specificity among general populations in Western settings, there is mixed evidence on the PHQ-9’s performance among PLWH in low-resource settings. In this study that used data from PLWH in 5 African countries, we found that PHQ-9 has low sensitivity and low positive predictive value (PPV) compared to diagnosis made by a psychiatrist, but high negative predictive values (NPV).  https://lnkd.in/em6GtdGU

Have a look at this systematic review that identifies the reasons people disengage from antiretroviral therapy (ART) care in low- or middle-income countries during the "Treat All" era. Key reasons include ART side effects, lack of perceived benefits, psychological issues, stigma concerns, socioeconomic factors, and health facility-related challenges. It emphasizes the complexity and interaction of factors leading to disengagement, highlighting the need for person-centered, welcoming, and flexible ART services alongside adherence interventions like counseling, peer support, among others already recommended by WHO. https://lnkd.in/drD6WpYX

#Funding opportunity! 🔥 In coordination with the White House Initiative on Women’s Health Research, ORWH and several NIH institutes and centers issued a Notice of Special Interest (NOSI) to highlight interest in receiving research applications focused on diseases and health conditions that predominantly affect women (e.g., autoimmune diseases, depressive disorders, Alzheimer’s disease and Alzheimer’s disease-related dementias, gender-based violence), present and progress differently in women (e.g., cardiovascular disease, HIV, reproductive aging and its implications), or are female specific (e.g., uterine fibroids, endometriosis, menopause). Applications should have a central focus on the health of women, as demonstrated through specific aims that either explicitly address a particular condition in women or focus on one of the high-priority topics. In each of these potential areas of focus, intersectional and/or multidimensional approaches to gender-related social and structural variables—including race, ethnicity, socioeconomic status , and state and federal policies—are strongly encouraged. The NOSI expires November 5, 2027. https://buff.ly/3WdJ2S2 #womenshealth #femtech #healthtech #digitalhealth #healthcare #healthcareinnovation #startups #innovation #health #medtech #healthcareresearch #femalehealth #genderhealthgap #reproductivehealth #venturecapital #vc #funding #investment #grants #maternalhealth #periods #menstruation #sexualhealth #sextech #menopause #fertility #pregnancy #postpartum #eggfreezing #IVF #healthequity #pelvicfloor #pelvicfloorhealth #hormonehealth

Do sexually transmitted diseases (STDs) cause erectile dysfunction (ED)? Certain STDs such as chlamydia, viral hepatitis, gonorrhea, and HIV may cause prostate infections that may interfere with your erectile and sexual function. This article will explain what ED is and how these STDs may affect your erections in detail. https://lnkd.in/euy5HgTf #UltraPharmRx #telehealth #telemedicine

In coordination with the White House Initiative on Women’s Health Research, The National Institutes of Health Office of Research on Women's Health issued a Notice of Special Interest to highlight interest in receiving research applications focused on diseases and health conditions predominantly affect women (e.g., #autoimmune diseases, depressive disorders, Alzheimer’s disease and Alzheimer’s disease-related dementias, gender-based violence), present and progress differently in women (e.g., #cardiovascular disease, #HIV, reproductive aging and its implications), or are female specific (e.g., uterine #fibroids, #endometriosis, #menopause). The NOSI expires November 5, 2027. Learn more: https://lnkd.in/g88ksaqM